Shelton Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,995
| Closed | -$211K | – | 739 |
|
|
2024
Q3 | $211K | Hold |
3,995
| – | – | 0.01% | 695 |
|
|
2024
Q2 | $216K | Sell |
3,995
-198
| -5% | -$10.7K | 0.01% | 646 |
|
|
2024
Q1 | $294K | Sell |
4,193
-458
| -10% | -$32.1K | 0.01% | 531 |
|
|
2023
Q4 | $388K | Buy |
+4,651
| New | +$388K | 0.01% | 388 |
|
|
2023
Q1 | – | Sell |
-5,392
| Closed | -$247K | – | 735 |
|
|
2022
Q4 | $247K | Hold |
5,392
| – | – | 0.03% | 527 |
|
|
2022
Q3 | $261K | Hold |
5,392
| – | – | 0.01% | 502 |
|
|
2022
Q2 | $212K | Buy |
+5,392
| New | +$212K | 0.01% | 644 |
|